Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
AIDS & HIV : Health & Medical
Antiretroviral Treatment and Age-related Comorbidities in Older HIV Patient
HIV-infected patients >50 years old constitute a new treatment challenge in terms of the cumulative effects of aging and antiretroviral therapy.
Using Drugs to Prevent HIV Infection: Who, What, and When?
Dr. Myron Cohen considers some of the key challenges facing clinicians in determining which patients might benefit from preexposure prophylaxis for HIV infection.
ART Use and Kidney Function: Clinical Practice Implications
What effect does antiretroviral therapy have on the kidney?
Discrimination & HIV
According to the U.K.'s HIV awareness campaign AVERT discrimination against people with HIV/AIDS takes many forms including prejudice, abuse, threats of physical violence, negative attitudes and maltreatment. The International Center for Research on Women explains that to instigate successful govern
How To Read HIV Test Results
Human immunodeficiency virus (HIV) is transmitted through blood after contact with an infected person or contaminated needle, and it is the virus that causes acquired immunodeficiency syndrome (AIDS). When the virus enters your body, your immune system responds by producing antibodies against it. La
HCV-Coinfection is Associated With Diabetes and CD4 Decline
Researchers recently recognized an association between hepatitis C virus (HCV) infection and diabetes mellitus.
Combination ART Reduces the Risk of HPV in HIV+ Women
Combination ART may protect HIV+ women from cervical HPV infections.
HIV and Risk of Venous Thromboembolism
Why are some HIV patients, especially those who inject drugs, at a high risk of venous thromboembolism?
Best of AIDS 2003: Clinical - A Randomized Trial Assessing the
Recent studies continue to demonstrate the need to utilize all clinically validated tools when changing regimens after virologic rebound.
Telaprevir-Based Triple Therapy for HIV/HCV Coinfection
This study compares the effectiveness of telaprevir-based triple therapy for hepatitis C in patients with and without HIV coinfection.
Editorial: Immune Reconstitution and HAART: An Update
Through several editorials over the past 2 years, I've raised the issue of methods to assess recovery of the immune system following HAART and complete suppression of detectable viral load, as well as arguments concerning the incidence, clinical impact, and durability of such immune reconstituti
Retention in HIV Care in Year 1: Who's In and Who's Out?
Which patients are less likely to be retained in HIV care?
News Briefs
Study results presented on interferon/ribavirin combination therapy... Drug abuse health services funding available... HIV drug resistance web site launched...
Adding Maraviroc to Suppressive ART Will Not Boost CD4
Adding maraviroc to ART is not a useful strategy for boosting CD4-cell counts in immunologic nonresponders.
HIV Facts
Since the 1980s, AIDS has ravaged communities throughout the world. The virus that causes the disease, known as the human immunodeficiency virus (HIV), first came to public attention in the 1980s. The virus and the disease have been known to take a heavy toll on many throughout the United States, mo
Using Drugs to Prevent HIV Infection: Who, What, and When?
Dr. Myron Cohen considers some of the key challenges facing clinicians in determining which patients might benefit from preexposure prophylaxis for HIV infection.
Smoking and Mortality in HIV Infection
Current smokers with HIV infection have 4 times higher risk for death than those without HIV infection.
Inadequate Monitoring and Attrition Among Patients on ART
What are the patient risk factors for failure to follow-up in HIV care?
Association of HIV Viral Load and CD4 Cell Count With HPV
A higher CD4 cell count after ART in HIV-positive women may have an impact on the control of HPV infection.